Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 12.14%

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has an Asset Resilience Ratio of 12.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Nanjing King-friend Biochemical Pharmace total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.25 Billion

≈ $183.16 Million USD Cash + Short-term Investments

Total Assets

CN¥10.31 Billion

≈ $1.51 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 603707 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Nanjing King-friend Biochemical Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603707 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.25 Billion	12.14%
Total Liquid Assets	CN¥1.25 Billion	12.14%

Asset Resilience Insights

Moderate Liquidity: Nanjing King-friend Biochemical Pharmaceutical Co Ltd has 12.14% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
KPC Pharmaceuticals Inc SHG:600422	Drug Manufacturers - Specialty & Generic	16.37%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Cheng Du Sheng Nuo Biotec Co. Ltd. A SHG:688117	Drug Manufacturers - Specialty & Generic	3.51%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	5.72%

Annual Asset Resilience Ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.10%	CN¥1.06 Billion ≈ $154.44 Million	CN¥9.51 Billion ≈ $1.39 Billion	+3.94pp
2023-12-31	7.16%	CN¥681.99 Million ≈ $99.80 Million	CN¥9.52 Billion ≈ $1.39 Billion	+7.15pp
2022-12-31	0.01%	CN¥1.30 Million ≈ $190.23K	CN¥10.01 Billion ≈ $1.46 Billion	-3.15pp
2021-12-31	3.16%	CN¥259.80 Million ≈ $38.02 Million	CN¥8.22 Billion ≈ $1.20 Billion	-7.79pp
2020-12-31	10.96%	CN¥845.79 Million ≈ $123.77 Million	CN¥7.72 Billion ≈ $1.13 Billion	+9.84pp
2019-12-31	1.12%	CN¥56.64 Million ≈ $8.29 Million	CN¥5.08 Billion ≈ $743.13 Million	-18.18pp
2017-12-31	19.30%	CN¥520.00 Million ≈ $76.09 Million	CN¥2.69 Billion ≈ $394.33 Million	+5.42pp
2015-12-31	13.87%	CN¥180.00 Million ≈ $26.34 Million	CN¥1.30 Billion ≈ $189.85 Million	+13.77pp
2014-12-31	0.11%	CN¥1.64 Million ≈ $239.56K	CN¥1.54 Billion ≈ $225.37 Million	--

pp = percentage points

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.15 Billion

CN¥14.70 Billion CNY

Market Cap Rank

#6068 Global

#1341 in China

Share Price

CN¥9.10

Change (1 day)

+0.00%

52-Week Range

CN¥9.03 - CN¥11.94

All Time High

CN¥33.62